GABRG2, rs211037 is associated with epilepsy susceptibility, but not with antiepileptic drug resistance and febrile seizures

Pharmacogenetics and Genomics

Volumn 23, Issue 11, 2013, Pages 605-610

  Balan, Shabeesh ^a,b   Sathyan, Sanish ^a   Radha, Saradalekshmi K ^a   Joseph, Vijai ^c   Radhakrishnan, Kurupath ^b   Banerjee, Moinak ^a  

^a RAJIV GANDHI CENTRE FOR BIOTECHNOLOGY   (India)

^b SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Antiepileptic drug resistance; Epilepsy; GABRG2; Hippocampal sclerosis; Juvenile myoclonic epilepsy; Temporal lobe epilepsy

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR GAMMA2; ANTICONVULSIVE AGENT;

ADULT; ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG RESISTANCE; FEBRILE CONVULSION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE PHENOTYPE CORRELATION; HIPPOCAMPAL SCLEROSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MESIAL TEMPORAL LOBE EPILEPSY; MYOCLONUS EPILEPSY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; ANTICONVULSANTS; CASE-CONTROL STUDIES; DRUG RESISTANCE; EPILEPSY; EPILEPSY, TEMPORAL LOBE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HIPPOCAMPUS; HUMANS; INDIA; MALE; MYOCLONIC EPILEPSY, JUVENILE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, GABA-A; SCLEROSIS; SEIZURES, FEBRILE; YOUNG ADULT;

EID: 84886601313     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0000000000000000     Document Type: Article

References (34)

1. Radhakrishnan K. Challenges in the management of epilepsy in resourcepoor countries. Nat Rev Neurol 2009; 5: 323-330.
2. Kwan P, Schachter SC, Brodie MJ. Drug-resistant epilepsy. N Engl J Med 2011; 365: 919-926.
3. Brodie M, Barry S, Bamagous G, Norrie J, Kwan P. Patterns of treatment response in newly diagnosed epilepsy. Neurology 2012; 78: 1548-1554.
4. Rogawski MA, Lö scher W. The neurobiology of antiepileptic drugs. Nat Rev Neurosci 2004; 5: 553-564.
5. Fritschy JM. Epilepsy, E/I balance and GABAA receptor plasticity. Frontiers Mol Neurosci 2008; 1: 5.
6. Tan NCK, Mulley JC, Berkovic SF. Genetic association studies in epilepsy: 'the truth is out there'. Epilepsia 2004; 45: 1429-1442.
7. Cavalleri GL, Lynch JM, Depondt C, Burley MW, Wood NW, Sisodiya SM, et al. Failure to replicate previously reported genetic associations with sporadic temporal lobe epilepsy: where to from here? Brain 2005; 128: 1832-1840.
8. Cavalleri GL, McCormack M, Alhusaini S, Chaila E, Delanty N. Pharmacogenomics and epilepsy: the road ahead. Pharmacogenomics 2011; 12: 1429-1447.
9. Greenberg DA, Stewart WCL. How should we be searching for genes for common epilepsy? A critique and a prescription. Epilepsia 2012; 53: 72-80.
10. Balan S, Vellichirammal NN, Banerjee M, Radhakrishnan K. Failure to find association between febrile seizures and SCN1A rs3812718 polymorphism in south Indian patients with mesial temporal lobe epilepsy and hippocampal sclerosis. Epilepsy Res 2012; 101: 288-292.
11. Ramesha KN, Mooney T, Sarma PS, Radhakrishnan K. Long-term seizure outcome and its predictors in patients with recurrent seizures during the first year after temporal lobe resective epilepsy surgery. Epilepsia 2011; 52: 917-924.
12. Rathore C, Sarma SP, Radhakrishnan K. Prognostic importance of serial postoperative EEGs after anterior temporal lobectomy. Neurology 2011; 76: 1925-1931.
13. Grunewald RA, Panayiotopoulos CP. Juvenile myoclonic epilepsy: a review. Arch Neurol 1993; 50: 594-598.
14. Vijai J, Cherian P, Sylaja P, Anand A, Radhakrishnan K. Clinical characteristics of a South Indian cohort of juvenile myoclonic epilepsy probands. Seizure 2003; 12: 490-496.
15. Kumari R, Lakhan R, Kalita J, Misra U, Mittal B. Association of alpha subunit of GABA A receptor subtype gene polymorphisms with epilepsy susceptibility and drug resistance in north Indian population. Seizure 2010; 19: 237-241.
16. Kumari R, Lakhan R, Kalita J, Garg R, Misra U, Mittal B. Potential role of GABAA receptor subunit; GABRA6, GABRB2 and GABRR2 gene polymorphisms in epilepsy susceptibility and pharmacotherapy in North Indian population. Clin Chim Acta 2011; 412: 1244-1248.
17. Macdonald RL, Kang JQ, Gallagher MJ. Mutations in GABAA receptor subunits associated with genetic epilepsies. J Physiol 2010; 588: 1861-1869.
18. Meldrum BS. Update on the mechanism of action of antiepileptic drugs. Epilepsia 2007; 37:S4-S11.
19. Brooks-Kayal AR, Shumate MD, Jin H, Rikhter TY, Coulter DA. Selective changes in single cell GABAA receptor subunit expression and function in temporal lobe epilepsy. Nat Med 1998; 4: 1166-1172.
20. Bethmann K, Fritschy JM, Brandt C, Lö scher W. Antiepileptic drug resistant rats differ from drug responsive rats in GABA A receptor subunit expression in a model of temporal lobe epilepsy. Neurobiol Dis 2008; 31: 169.
21. Chou I, Lee CC, Tsai CH, Tsai Y, Wan L, Hsu YA, et al. Association of GABRG2 polymorphisms with idiopathic generalized epilepsy. Pediatr Neurol 2007; 36: 40-44.
22. Kinirons P, Cavalleri GL, Shahwan A, Wood NW, Goldstein DB, Sisodiya SM, et al. Examining the role of common genetic variation in the g2 subunit of the GABAA receptor in epilepsy using tagging SNPs. Epilepsy Res 2006; 70: 229-238.
23. Cavalleri GL, Weale ME, Shianna KV, Singh R, Lynch JM, Grinton B, et al. Multicentre search for genetic susceptibility loci in sporadic epilepsy syndrome and seizure types: a case-control study. Lancet Neurol 2007; 6: 970-980.
24. Thomas R, Nair S, Banerjee M. A crypto-Dravidian origin for the nontribal communities of South India based on human leukocyte antigen class I diversity. Tissue Antigens 2006; 68: 225-234.
25. Reich D, Thangaraj K, Patterson N, Price AL, Singh L. Reconstructing Indian population history. Nature 2009; 461: 489-494.
26. Gü nther U, Benson J, Benke D, Fritschy JM, Reyes G, Knoflach F, et al. Benzodiazepine-insensitive mice generated by targeted disruption of the gamma 2 subunit gene of gamma-aminobutyric acid type A receptors. Proc Natl Acad Sci USA 1995; 92: 7749-7753.
27. Essrich C, Lorez M, Benson JA, Fritschy JM, Luscher B. Postsynaptic clustering of major GABAA receptor subtypes requires the gamma 2 subunit and gephyrin. Nat Neurosci 1998; 1: 563-571.
28. Schweizer C, Balsiger S, Bluethmann H, Mansuy IM, Fritschy JM, Mohler H, et al. The g2 subunit of GABA(A) receptors is required for maintenance of receptors at mature synapses. Mol Cell Neurosci 2003; 24: 442-450.
29. Kimchi-Sarfaty C, Oh JM, Kim IW, Sauna ZE, Calcagno AM, Ambudkar SV, et al. A 'silent' polymorphism in the MDR1 gene changes substrate specificity. Science 2007; 315: 525-528.
30. Chou IC, Peng CT, Huang CC, Tsai JJP, Tsai FJ, Tsai CH. Association analysis of gamma 2 subunit of gamma-aminobutyric acid type A receptor polymorphisms with febrile seizures. Pediatr Res 2003; 54: 26-29.
31. Salam SMA, Rahman HMA, Karam RA. GABRG2 gene polymorphisms in Egyptian children with simple febrile seizures. Indian J Pediatr 2012; 79: 1514-1516.
32. Nakayama J, Hamano K, Noguchi E, Horiuchi Y, Iwasaki N, Ohta M, et al. Failure to find causal mutations in the GABAA-receptor g2 subunit (GABRG2) gene in Japanese febrile seizure patients. Neurosci Lett 2003; 343: 117-120.
33. Ma S, Abou-Khalil B, Blair MA, Sutcliffe JS, Haines JL, Hedera P. Mutations in GABRA1, GABRA5, GABRG2 and GABRD receptor genes are not a major factor in the pathogenesis of familial focal epilepsy preceded by febrile seizures. Neurosci Lett 2006; 394: 74-78.
34. Haerian BS, Baum L. GABRG2 rs211037 polymorphism and epilepsy: a systematic review and meta-analysis. Seizure 2013; 22: 53-58.